Concise review: Defining and targeting myeloma stem cell-like cells (Q38180656)

30 August 2017

Concise review: Defining and targeting myeloma stem cell-like cells (English)

1 reference

30 August 2017

Masahiro Abe

1

1 reference

PubMed ID

24449391

30 August 2017

Takeshi Harada

series ordinal

2

1 reference

PubMed ID

24449391

30 August 2017

Toshio Matsumoto

series ordinal

3

1 reference

30 August 2017

1 May 2014

1 reference

30 August 2017

1 reference

30 August 2017

32

1 reference

30 August 2017

5

1 reference

30 August 2017

1067-1073

1 reference

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

30 August 2017

1 reference

Targeting cancer stem cells.

21 January 2018

1 reference

Identification of human brain tumour initiating cells

21 January 2018

1 reference

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell

21 January 2018

1 reference

Characterization of clonogenic multiple myeloma cells

21 January 2018

1 reference

Stemness of B-cell progenitors in multiple myeloma bone marrow

21 January 2018

1 reference

A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma

21 January 2018

1 reference

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

21 January 2018

1 reference

Primary Bioassay of Human Myeloma Stem Cells

21 January 2018

1 reference

Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma.

21 January 2018

1 reference

CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.

21 January 2018

1 reference

CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype

21 January 2018

1 reference

Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma

21 January 2018

1 reference

A side order of stem cells: the SP phenotype

21 January 2018

1 reference

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells

21 January 2018

1 reference

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

21 January 2018

1 reference

Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors

21 January 2018

1 reference

Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells

21 January 2018

1 reference

Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state

21 January 2018

1 reference

Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype

21 January 2018

1 reference

Advances in the biology and treatment of bone disease in multiple myeloma

21 January 2018

1 reference

Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma

21 January 2018

1 reference

Advances in the understanding of myeloma bone disease and tumour growth

21 January 2018

1 reference

The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts.

21 January 2018

1 reference

Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models.

21 January 2018

1 reference

The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.

21 January 2018

1 reference

The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype

21 January 2018

1 reference

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

21 January 2018

1 reference

CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth

21 January 2018

1 reference

The engine driving the ship: metabolic steering of cell proliferation and death.

21 January 2018

1 reference

Cellular life span and the Warburg effect

21 January 2018

1 reference

Regulation of cancer cell metabolism

21 January 2018

1 reference

Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate

21 January 2018

1 reference

MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors

21 January 2018

1 reference

ABC transporters in cancer: more than just drug efflux pumps.

21 January 2018

1 reference

ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy

21 January 2018

1 reference

Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells

21 January 2018

1 reference

2D7 diabody bound to the alpha2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells

21 January 2018

1 reference

A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment

21 January 2018

1 reference

Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms

21 January 2018

1 reference

Anti-CD20 monoclonal antibody therapy in multiple myeloma.

21 January 2018

1 reference

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

21 January 2018

1 reference

Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma

21 January 2018

1 reference

Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy

21 January 2018

1 reference

Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma.

21 January 2018

1 reference

Core transcriptional regulatory circuitry in human embryonic stem cells

21 January 2018

1 reference

Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming

21 January 2018

1 reference

Wnt signaling promotes reprogramming of somatic cells to pluripotency

21 January 2018

1 reference

Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells

21 January 2018

1 reference

Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/STEM.1643

1 reference

30 August 2017

1 reference

PubMed ID

24449391